Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06339827 · ClinicalTrials.gov registry record · NA

ASk Questions in GYnecologic Oncology (ASQ-GYO)

A NA study of Ovarian Cancer and Endometrial Cancer, sponsored by Ira Winer.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06339827 is a NA study of Ovarian Cancer and Endometrial Cancer that is actively recruiting participants, run by Ira Winer. The registered enrollment target is 70 participants, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06339827, a NA study of Ovarian Cancer and Endometrial Cancer, is actively recruiting participants, sponsored by Ira Winer.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

Interventions

  • BEHAVIORAL Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List

Study Locations (1)

Michigan

  • Barbara Ann Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-04-04
Est. Completion 2028-05
Phase NA

Sponsor

Ira Winer

2 total trials

What the Registry Record Tells You About NCT06339827

The ClinicalTrials.gov registry entry for NCT06339827 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Ira Winer, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List is the first listed.

NCT06339827 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06339827 about?

NCT06339827 is a clinical study titled "ASk Questions in GYnecologic Oncology (ASQ-GYO)". The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also t...

What is the current status of trial NCT06339827?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-04. Estimated completion is 2028-05.

What conditions does trial NCT06339827 study?

This clinical trial studies the following conditions: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Vulvar Cancer, Vaginal Cancer.

What interventions are being tested in trial NCT06339827?

The interventions under investigation include: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List (BEHAVIORAL).

Who is sponsoring clinical trial NCT06339827?

This trial is sponsored by Ira Winer, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06339827 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovarian Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.